BioNTech SE (BNTX)
106.39
+0.63
(+0.60%)
USD |
NASDAQ |
Feb 13, 14:14
BioNTech Free Cash Flow : -588.89M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CureVac NV | -144.00M |
| Novavax, Inc. | -384.71M |
| Pfizer Inc. | 10.38B |
| Sanofi | 12.54B |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 854.07M |
| Cash from Investing (Quarterly) | -994.84M |
| Cash from Financing (Quarterly) | -14.05M |
| Free Cash Flow Per Share (Quarterly) | 3.262 |
| Free Cash Flow to Equity (Quarterly) | 812.49M |
| Free Cash Flow to Firm (Quarterly) | 783.82M |
| Free Cash Flow Yield | -2.30% |